Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(10 sites)

United States

Helios CR Inc./RadNet, Cerritos, California

Hoag Memorial Hospital, Irvine, California

UCLA, Los Angeles, California

Moffit Cancer Center, Tampa, Florida

Indiana University Health University Hospital, Indianapolis, Indiana

Massachusetts General Hospital, Boston, Massachusetts

UMass/Shields, Worcester, Massachusetts

Memorial Sloan Kettering Cancer Center, New York, New York

Cleveland Clinic, Cleveland, Ohio

Kettering, Kettering, Ohio